Anebulo Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 14
Rang # Quantité totale PI 108 652
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 41 112
Symbole boursier ANEB (nasdaq)
ISIN US0345691036
Capitalisation 42.80M  (USD)

Brevets

Marques

7 0
2 0
5 0
0
 
Dernier brevet 2025 - Parenteral formulations of cb1 i...
Premier brevet 2020 - Formulations and methods for tre...

Derniers inventions, produits et services

2024 Invention Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and prepara...
Invention Parenteral formulations of cb1 inhibitors and methods of use. Provided herein are methods of trea...
2023 Invention Treatment of acute cannabinoid overdose. Provided herein are methods of treating cannabinoid into...
2022 Invention Method of treating addiction. Described herein are methods of combination therapy for treating a...
Invention Method of treating addiction. Described herein are methods of combination therapy for treating ad...
2021 Invention Formulations and methods for treating acute cannabinoid overdose. Described herein are uses of t...
Invention Formulations and methods for treating acute cannabinoid overdose. Described herein are uses of th...